Supplement for mothers during pregnancy and after childbirth
Official title: PEER-CM Peripartum Supplement
Funded at Oregon Health & Science University · NIH-11096428 · Data updated 2026-11-12
This study is looking at how a special supplement can help moms and their babies during the time around childbirth, and we're inviting mothers to join us to see if it can improve their health and their little one's health too!
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2025 |
| Funding year | 2024 |
| Award (this year) | $178,938 |
| NIH project number | 3R01DA057670-01S1 |
| Project ID | NIH-11096428 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pregnant women or new mothers who are seeking support for their health during and after pregnancy.
✕Less likely to help
Patients who are not pregnant or who have already given birth more than a year ago may not receive benefit from this research.
What this research studies
This research investigates the effects of a specific supplement on mothers during the peripartum period, which includes the time just before and after childbirth. The study aims to understand how this supplement can improve health outcomes for both mothers and their children. Participants will be monitored for various health indicators, and the research will involve collaboration with healthcare providers to ensure best practices are followed. The goal is to gather data that can inform future guidelines for maternal and child health.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for mothers and their newborns during a critical time.
How similar studies have gone: Previous research has shown promising results with similar supplements in improving maternal and child health outcomes.
Where this research is happening
-
Oregon Health & Science University
Portland, United States Active
Researchers
- Principal investigator: Korthuis, Philip Todd — Oregon Health & Science University
- Study coordinator: Korthuis, Philip Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.